Aberrant AKT activation drives well-differentiated liposarcoma

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 39, 2011, Pages 16386-16391

  Gutierrez, Alejandro ^a,b   Snyder, Eric L ^a,c,d   Marino Enriquez, Adrian ^c   Zhang, Yi Xiang ^a   Sioletic, Stefano ^a   Kozakewich, Elena ^a   Grebliunaite, Ruta ^a   Ou, Wen Bin ^c   Sicinska, Ewa ^a   Raut, Chandrajit P ^a,c   Demetri, George D ^a   Perez Atayde, Antonio R ^b   Wagner, Andrew J ^a   Fletcher, Jonathan A ^a,c   Fletcher, Christopher D M ^c   Look, A Thomas ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (1 CYANO 1 METHYLETHYL) 3 METHYL 8 (3 QUINOLINYL)IMIDAZO[4,5 C]QUINOLIN 2(1H,3H) ONE; PROTEIN KINASE B; PROTEIN P53;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INCIDENCE; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; DEDIFFERENTIATED LIPOSARCOMA; EMBRYO; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIPOSARCOMA; MESENCHYMAL STEM CELL; MUTATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WELL DIFFERENTIATED LIPOSARCOMA; WESTERN BLOTTING; WILD TYPE; ZEBRA FISH;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL DIFFERENTIATION; ENZYME ACTIVATION; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOSARCOMA; MUTATION; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; TOR SERINE-THREONINE KINASES; ZEBRAFISH;

ANIMALIA; DANIO RERIO; MAMMALIA;

EID: 80053653485     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1106127108     Document Type: Article

References (26)

1. Dalal KM, Antonescu CR, Singer S (2008) Diagnosis and management of lipomatous tumors. J Surg Oncol 97:298-313. (Pubitemid 351358578)
2. Fletcher CDM, Unni KK, Mertens F eds (2002) Pathology and Genetics of Tumours of Soft Tissue and Bone (IARC Press, Lyon).
3. Kransdorf MJ (1995) Malignant soft-tissue tumors in a large referral population: Distribution of diagnoses by age, sex, and location. AJR Am J Roentgenol 164:129-134.
4. Dei Tos AP, Pedeutour F (2002) Atypical lipomatous tumor/well differentiated liposarcoma; Dedifferentiated liposarcoma. Pathology and Genetics of Tumors of Soft Tissue and Bone: World Health Organization Classification of Tumors., ed Fletcher CDM (IARC press, Lyon), pp 35-39.
5. Jones RL, Fisher C, Al-Muderis O, Judson IR (2005) Differential sensitivity of liposarcoma subtypes to chemotherapy. Eur J Cancer 41:2853-2860. (Pubitemid 41713123)
6. Conyers R, Young S, Thomas DM (2011) Liposarcoma: Molecular genetics and therapeutics. Sarcoma 2011:483154.
7. Leach FS, et al. (1993) p53 Mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 53(10, Suppl):2231-2234. (Pubitemid 23156805)
8. Pilotti S, et al. (1997) Distinct mdm2/p53 expression patterns in liposarcoma subgroups: Implications for different pathogenetic mechanisms. J Pathol 181:14-24. (Pubitemid 27099769)
9. Schneider-Stock R, et al. (1998) MDM2 amplification and loss of heterozygosity at Rb and p53 genes: no simultaneous alterations in the oncogenesis of liposarcomas. J Cancer Res Clin Oncol 124:532-540. (Pubitemid 28513115)
10. Italiano A, et al. (2008) HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon. Int J Cancer 122:2233-2241. (Pubitemid 351542325)
11. Debelenko LV, et al. (2010) p53+/mdm2- atypical lipomatous tumor/well-differentiated liposarcoma in young children: an early expression of Li-Fraumeni syndrome. Pediatr Dev Pathol 13:218-224.
12. Pedeutour F, et al. (1999) Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer 24:30-41. (Pubitemid 28544460)
13. Barretina J, et al. (2010) Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Nat Genet 42:715-721.
14. Snyder EL, et al. (2009) c-Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme. J Pathol 218:292-300.
15. Liu P, Cheng H, Roberts TM, Zhao JJ (2009) Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 8:627-644.
16. Marsh DJ, et al. (1999) PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet 8:1461-1472. (Pubitemid 29374079)
17. Hernando E, et al. (2007) The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas. Nat Med 13:748-753. (Pubitemid 46889749)
18. Berghmans S, et al. (2005) tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc Natl Acad Sci USA 102:407-412. (Pubitemid 40116780)
19. Tan Y, et al. (2008) A novel recurrent chromosomal inversion implicates the homeobox gene Dlx5 in T-cell lymphomas from Lck-Akt2 transgenic mice. Cancer Res 68:1296-1302. (Pubitemid 351346835)
20. Langenau DM, et al. (2007) Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes Dev 21:1382-1395. (Pubitemid 46871041)
21. Hay N, Sonenberg N (2004) Upstream and downstream of mTOR. Genes Dev 18:1926-1945. (Pubitemid 39071573)
22. Maira SM, et al. (2008) Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. Mol Cancer Ther 7:1851-1863.
23. Carnevalli LS, et al. (2010) S6K1 plays a critical role in early adipocyte differentiation. Dev Cell 18:763-774.
24. Westerfield M (1994) The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish (Brachydanio rerio) (University of Oregon Press, Eugene, OR); 2.1 Ed.
25. Jessen JR, Jessen TN, Vogel SS, Lin S (2001) Concurrent expression of recombination activating genes 1 and 2 in zebrafish olfactory sensory neurons. Genesis 29:156-162. (Pubitemid 32417238)
26. Gutierrez A, et al. (2011) Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia. J Exp Med 208:1595-1603.